Arley360

A new study has introduced a promising blood test that health professionals may soon use to accurately detect brain cancer. Dr. Matthew J. Baker, a reader in the Department of Pure and Applied Chemistry at the University of Strathclyde in Glasgow, United Kingdom, is the lead author of the new research. He and his colleagues have now published their findings in the journal Nature Communications. Of the study, Dr. Baker says, "This is the first publication of data from our clinical feasibility study, and it is the first demonstration that our blood test works in the clinic." Although it is quite rare, brain cancer often has a poor outlook. According to the National Cancer Institute, around 0.6% of people will develop brain cancer or another cancer of the nervous system in their lifetime. However, the 5 year survival rate for those who do receive such a diagnosis is less than 33%. Largely, the poor outlook is due to the fact that brain tumors have very nonspecific symptoms, which makes them